Holen Sie sich die Stockscreener-App
3.79
6.16%
0.22
Handel nachbörslich:
3.88
0.09
+2.37%
Schlusskurs vom Vortag:
$3.57
Offen:
$3.56
24-Stunden-Volumen:
2.83M
Relative Volume:
0.32
Marktkapitalisierung:
$60.67M
Einnahmen:
$1.38M
Nettoeinkommen (Verlust:
$-179.05M
KGV:
-0.6173
EPS:
-6.14
Netto-Cashflow:
$-155.03M
1W Leistung:
-6.42%
1M Leistung:
+27.61%
6M Leistung:
+38.83%
1J Leistung:
+542.26%
1-Tages-Spanne:
$3.56
$4.0397
1-Wochen-Bereich:
$3.41
$4.20
52-Wochen-Spanne:
$0.16
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
Firmenname
Bioxcel Therapeutics Inc
Sektor
Branche
Telefon
203-643-8060
Adresse
555 LONG WHARF DRIVE, NEW HAVEN, CT
Vergleichen Sie BTAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
3.79 | 51.97M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-21 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-15 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-07-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-03-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-01 | Hochstufung | Goldman | Sell → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-06 | Bestätigt | BofA Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-30 | Eingeleitet | Goldman | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-04 | Eingeleitet | Guggenheim | Buy |
| 2020-04-01 | Eingeleitet | BofA/Merrill | Buy |
| 2020-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Bioxcel Therapeutics Inc Aktie (BTAI) Neueste Nachrichten
Can momentum traders help lift BioXcel Therapeutics Inc.Weekly Market Summary & Fast Entry and Exit Trade Plans - Newser
Is BioXcel Therapeutics Inc. part of any major indexJuly 2025 Macro Moves & Verified Swing Trading Watchlist - خودرو بانک
Published on: 2025-09-05 14:41:42 - Newser
Using data models to predict BioXcel Therapeutics Inc. stock movementSwing Trade & Weekly Watchlist for Hot Stocks - Newser
Can machine learning forecast BioXcel Therapeutics Inc. recoveryTrade Risk Report & Fast Entry High Yield Stock Tips - Newser
Can a trend reversal in BioXcel Therapeutics Inc. lead to recovery2025 Earnings Impact & Precise Swing Trade Alerts - Newser
What candlestick patterns are forming on BioXcel Therapeutics Inc.Earnings Overview Report & Fast Momentum Stock Entry Tips - Newser
Using Bollinger Bands to evaluate BioXcel Therapeutics Inc.July 2025 Retail & Real-Time Chart Pattern Alerts - Newser
Sector ETF performance correlation with BioXcel Therapeutics Inc.Weekly Market Summary & Comprehensive Market Scan Insights - Newser
How cyclical is BioXcel Therapeutics Inc.’s revenue stream2025 Pullback Review & Reliable Trade Execution Plans - خودرو بانک
Is BioXcel Therapeutics Inc. stock poised for growthWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Will BioXcel Therapeutics Inc. see short term momentumQuarterly Market Summary & Verified Swing Trading Watchlist - Newser
Published on: 2025-09-04 06:34:10 - Newser
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
AI-Driven Neuroscience Biotech BioXcel Therapeutics to Showcase Pipeline at Global Investment Conference - Stock Titan
BioXcel Therapeutics announces SERENITY Phase 3 trial met primary endpoint - MSN
Trend analysis for BioXcel Therapeutics Inc. this weekWeekly Profit Analysis & Growth Focused Investment Plans - Newser
Is BioXcel Therapeutics Inc. reversing from oversold territoryMarket Volume Summary & Low Risk Profit Maximizing Plans - Newser
Is BioXcel Therapeutics Inc. a speculative investmentMarket Trend Review & Target Return Focused Picks - خودرو بانک
BioXcel's agitation drug meets main goal in at-home study - MSN
What’s next for BioXcel Therapeutics Inc. stock2025 Fundamental Recap & Daily Chart Pattern Signals - خودرو بانک
What Fibonacci levels say about BioXcel Therapeutics Inc. reboundJuly 2025 Pullbacks & Safe Capital Growth Plans - Newser
Custom strategy builders for tracking BioXcel Therapeutics Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Is it too late to sell BioXcel Therapeutics Inc.Weekly Stock Report & Daily Volume Surge Trade Alerts - Newser
Will BioXcel Therapeutics Inc. stock recover after recent dropEarnings Summary Report & Daily Stock Momentum Reports - Newser
Risk vs reward if holding onto BioXcel Therapeutics Inc.Market Movement Recap & Step-by-Step Trade Execution Guides - Newser
Is BioXcel Therapeutics Inc. a strong candidate for buy and hold2025 Support & Resistance & Precise Swing Trade Alerts - khodrobank.com
Detecting price anomalies in BioXcel Therapeutics Inc. with AIAnalyst Upgrade & Growth Oriented Trading Recommendations - Newser
BioXcel Therapeutics Inc. stock momentum explained2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
Risk adjusted return profile for BioXcel Therapeutics Inc. analyzedRecession Risk & Low Drawdown Investment Ideas - Newser
BioXcel Therapeutics' (BTAI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Will BioXcel Therapeutics Inc. outperform the marketTrade Exit Summary & Consistent Growth Stock Picks - Newser
Will BioXcel Therapeutics Inc. benefit from green energy policies2025 Short Interest & Reliable Volume Spike Alerts - خودرو بانک
BioXcel shares rise on positive Phase 3 safety trial results - MSN
Real time breakdown of BioXcel Therapeutics Inc. stock performancePortfolio Return Summary & Low Risk Growth Stock Ideas - Newser
Is BioXcel Therapeutics Inc.’s growth already priced inJuly 2025 Trends & Weekly High Return Stock Forecasts - خودرو بانک
Is BioXcel Therapeutics Inc. Forming a Consolidation Base2025 Price Momentum & Accurate Intraday Trading Signals - beatles.ru
What data driven models say about BioXcel Therapeutics Inc.’s futureRisk Management & Free High Accuracy Swing Entry Alerts - Newser
How moving averages guide BioXcel Therapeutics Inc. tradingQuarterly Performance Summary & Low Risk High Win Rate Picks - Newser
Applying Wyckoff theory to BioXcel Therapeutics Inc. stockWeekly Gains Report & Community Verified Trade Alerts - Newser
Using portfolio simulators with BioXcel Therapeutics Inc. includedEarnings Recap Report & Weekly High Conviction Ideas - Newser
Should you hold or exit BioXcel Therapeutics Inc. now2025 Trading Recap & AI Forecasted Entry/Exit Points - Newser
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bioxcel Therapeutics Inc-Aktie (BTAI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mehta Vimal | CEO and President |
Dec 16 '24 |
Sale |
0.36 |
3,117 |
1,131 |
59,605 |
| Steinhart Richard I | Chief Financial Officer |
Dec 16 '24 |
Sale |
0.36 |
577 |
207 |
20,932 |
| Rodriguez Javier | See Remarks |
Dec 16 '24 |
Sale |
0.36 |
430 |
153 |
24,423 |
| Yocca Frank | Chief Scientific Officer |
Dec 16 '24 |
Sale |
0.35 |
430 |
152 |
28,931 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):